GIMAP5 and diabetes mellitus: This process aimed to dissect the mechanisms by which homozygous BB DR Major Histocompatibility Complex (MHC) RT.1Bu/u interacts with the Gimap5 deletion to induce early lymphopenia and diabetes at 50–70 days of age [5, 14, 45–47].